STX-1150

N/A

Report date: 2026/03/13 20:02:36

Base Information

Drug NameSTX-1150
Drug Alias NameSTX1150STX-1150
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsHypercholesterolemiaCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesScribe Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesScribe Therapeutics IncMonash University
Inactive CompaniesN/A
Active IndicationsHypercholesterolemiaCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A